0001752724-24-053397.txt : 20240313
0001752724-24-053397.hdr.sgml : 20240313
20240313125337
ACCESSION NUMBER: 0001752724-24-053397
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
EFFECTIVENESS DATE: 20240313
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alger ETF Trust
CENTRAL INDEX KEY: 0001807486
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-23603
FILM NUMBER: 24745266
BUSINESS ADDRESS:
STREET 1: 100 PEARL STREET
STREET 2: 27TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
BUSINESS PHONE: 212-806-8833
MAIL ADDRESS:
STREET 1: 100 PEARL STREET
STREET 2: 27TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
0001807486
S000069955
Alger Mid Cap 40 ETF
C000222788
Alger Mid Cap 40 ETF
FRTY
0001807486
S000069956
Alger 35 ETF
C000222789
Alger 35 ETF
ATFV
0001807486
S000079631
Alger Weatherbie Enduring Growth ETF
C000240821
Alger Weatherbie Enduring Growth ETF
AWEG
0001807486
S000084280
Alger Concentrated Equity ETF
C000248577
Alger Concentrated Equity ETF
0001807486
S000084281
Alger Artificial Intelligence ETF
C000248578
Alger Artificial Intelligence ETF
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001807486
XXXXXXXX
811-23603
true
false
false
N-1A
true
Alger ETF Trust
811-23603
0001807486
5493001LMS20X4PV3S52
100 Pearl Street
New York
10004-6030
US-NY
US
(800) 223-3810
Fred Alger & Company, LLC
100 Pearl Street
New York
10004-6030
212-806-8800
Records related to its functions as distributor
BROWN BROTHERS HARRIMAN & CO.
50 Post Office Square
Boston
02110-1548
617-772-1818
Records related to its functions as custodian, accounting agent and transfer agent
Fred Alger Management, LLC
100 Pearl Street
New York
10004-6030
212-806-8800
Records related to its functions as advisor, administrator, and shareholder servicing agent
Weatherbie Capital, LLC
265 Franklin Street
Boston
02110-3158
617-951-2550
Records related to its functions as sub-advisor
N
N
N-1A
3
Y
Charles F. Baird
N/A
N
Nathan E. Saint-Amand M.D.
N/A
N
Hilary M. Alger
001164468
Y
David Rosenberg
N/A
N
Tina Payne
005391957
100 Pearl Street
New York
10004-6030
XXXXXX
N
N
N
N
N
N
Fred Alger & Company, LLC
008-15900
000005300
549300RNUBAZ7ALEZI84
Y
N
Deloitte & Touche LLP
34
549300FJV7IV1ZHGAV28
N
N
N
N
N
N
N
Alger 35 ETF
S000069956
549300XPINPN13F35A88
N
1
0
0
Exchange-Traded Fund
Y
N
Y
N
N/A
0.00000000
0.00000000
Rule 18f-4 (17 CFR 270.18f-4)
Rule 32a-4 (17 CFR 270.32a-4)
Rule 17e-1 (17 CFR 270.17e-1)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Y
Y
Y
N
Fred Alger Management, LLC
801-6709
000106750
549300TITGLG7BXCGB39
N
Brown Brothers Harriman & Co.
084-06072
5493006KMX1VFTPYPW14
N
N
N
Refinitiv US LLC
213800HQORQAP68CJJ04
N
N
BROWN BROTHERS HARRIMAN AND CO
5493006KMX1VFTPYPW14
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Fred Alger Management, LLC
549300TITGLG7BXCGB39
Y
N
N
Fred Alger Management, LLC
549300TITGLG7BXCGB39
Y
N
Brown Brothers Harriman & Co.
5493006KMX1VFTPYPW14
N
Y
N
Fred Alger & Company, LLC
008-15900
000005300
549300RNUBAZ7ALEZI84
7887.11000000
Bay Crest Partners, LLC
008-48931
000039944
549300CTRRO8C3BU3H64
3215.57000000
LPS CAPITAL LLC
008-68706
000155246
54930066TNBSV20OYC83
1753.15000000
BTIG, LLC
008-65473
000122225
549300GTG9PL6WO3EC51
1549.54000000
ABEL NOSER, L.L.C.
008-69809
000284714
549300UQY3DBDP2Y2N55
3478.81000000
STIFEL, NICOLAUS & COMPANY, INCORPORATED
008-01447
000000793
5WUVMA08EYG4KEUPW589
2537.42000000
Jefferies LLC
008-15074
000002347
58PU97L1C0WSRCWADL48
2064.17000000
PIPER JAFFRAY & CO.
08-15204
000000665
549300GRQCWQ3XGH0H10
8346.42000000
CANACCORD GENUITY WEALTH MANAGEMENT (USA) INC.
008-21025
000007749
549300Y8YMXR5LZ07B04
CA
5141.97000000
Fred Alger & Company, LLC
008-15900
000005300
549300RNUBAZ7ALEZI84
7887.11000000
Wells Fargo Securities LLC
008-65876
000126292
VYVVCKR63DVZZN70PB21
8389.39000000
59322.80000000
0.00000000
Y
11262773.26000000
N
N
N
Alger Mid Cap 40 ETF
S000069955
549300BGEV4QVML5IV31
N
1
0
0
Exchange-Traded Fund
Y
N
Y
N
N/A
0.00000000
0.00000000
Rule 17e-1 (17 CFR 270.17e-1)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Rule 18f-4 (17 CFR 270.18f-4)
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
Y
N
Fred Alger Management, LLC
801-6709
000106750
549300TITGLG7BXCGB39
N
Brown Brothers Harriman & Co.
084-06072
5493006KMX1VFTPYPW14
N
N
N
Refinitiv US LLC
213800HQORQAP68CJJ04
N
N
BROWN BROTHERS HARRIMAN AND CO
5493006KMX1VFTPYPW14
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Fred Alger Management, LLC
549300TITGLG7BXCGB39
Y
N
N
Fred Alger Management, LLC
549300TITGLG7BXCGB39
Y
N
Brown Brothers Harriman & Co.
5493006KMX1VFTPYPW14
N
Y
N
Fred Alger & Company, LLC
008-15900
000005300
549300RNUBAZ7ALEZI84
6733.40000000
OPPENHEIMER & CO. INC.
008-04077
000000249
254900VH02JQR2L8XD64
4542.22000000
Wells Fargo Securities LLC
008-65876
000126292
VYVVCKR63DVZZN70PB21
5068.11000000
BERENBERG BANK Stiftung von 1990
N/A
N/A
5299000WI2BXRB3KKL92
DE
4298.47000000
BTIG, LLC
008-65473
000122225
549300GTG9PL6WO3EC51
2136.29000000
MORGAN STANLEY & CO. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
4239.06000000
Citigroup Global Markets Inc.
008-08177
000007059
MBNUM2BPBDO7JBLYG310
2184.62000000
Fred Alger & Company, LLC
008-15900
000005300
549300RNUBAZ7ALEZI84
6733.40000000
Bay Crest Partners, LLC
008-48931
000039944
549300CTRRO8C3BU3H64
3791.90000000
PIPER JAFFRAY & CO.
08-15204
000000665
549300GRQCWQ3XGH0H10
9388.39000000
CANACCORD GENUITY WEALTH MANAGEMENT (USA) INC.
008-21025
000007749
549300Y8YMXR5LZ07B04
CA
6603.76000000
75836.28000000
Citigroup Global Markets Inc.
008-08177
000007059
MBNUM2BPBDO7JBLYG310
44820.00000000
Goldman Sachs & Co, LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
423276.00000000
STIFEL, NICOLAUS & COMPANY, INCORPORATED
008-01447
000000793
5WUVMA08EYG4KEUPW589
1998424.02000000
2466520.02000000
Y
27603059.44000000
N
N
N
Alger Weatherbie Enduring Growth ETF
S000079631
549300KIDNFBXODQU524
Y
1
1
0
Exchange-Traded Fund
Y
N
Y
N
N/A
0.00000000
0.00000000
Rule 18f-4 (17 CFR 270.18f-4)
Rule 17e-1 (17 CFR 270.17e-1)
Rule 32a-4 (17 CFR 270.32a-4)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Y
Y
Y
N
Fred Alger Management, LLC
801-6709
000106750
549300TITGLG7BXCGB39
N
Weatherbie Capital, LLC
801-50672
000105991
N/A
Y
Brown Brothers Harriman & Co.
084-06072
5493006KMX1VFTPYPW14
N
N
N
Refinitiv US LLC
213800HQORQAP68CJJ04
N
N
BROWN BROTHERS HARRIMAN AND CO
5493006KMX1VFTPYPW14
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
EUROCLEAR BANK SA NV
549300OZ46BRLZ8Y6F65
BE
N
Y
Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7)
N
Fred Alger Management, LLC
549300TITGLG7BXCGB39
Y
N
N
Brown Brothers Harriman & Co.
5493006KMX1VFTPYPW14
N
Y
Fred Alger Management, LLC
549300TITGLG7BXCGB39
Y
N
N
Fred Alger & Company, LLC
008-15900
000005300
549300RNUBAZ7ALEZI84
0.00000000
CANACCORD GENUITY WEALTH MANAGEMENT (USA) INC.
008-21025
000007749
549300Y8YMXR5LZ07B04
CA
142.81000000
COWEN AND COMPANY, LLC
008-22522
000007616
549300WR155U7DVMIW58
144.94000000
ROYAL BANK OF CANADA
N/A
N/A
ES7IP3U3RHIGC71XBU11
CA
218.78000000
Needham & Company, LLC
008-33772
000016360
254900J2GFQ4J4NK1J89
60.63000000
Virtu Americas LLC
008-68193
000149823
549300RA02N3BNSWBV74
652.85000000
LIQUIDNET INC.
008-52461
000103987
213800HSKBBO1GCVRG79
89.62000000
RAYMOND JAMES (USA) LTD.
008-42071
000025853
9845000D4AB6D9B2AA23
CA
113.94000000
Goldman Sachs & Co, LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
45.82000000
OPPENHEIMER & CO. INC.
008-04077
000000249
254900VH02JQR2L8XD64
165.70000000
MERRILL LYNCH, PIERCE, FENNER & SMITH INC.
008-07221
000007691
8NAV47T0Y26Q87Y0QP81
271.41000000
2078.45000000
0.00000000
Y
3643124.88000000
N
N
N
Alger 35 ETF
S000069956
N
12500.00000000
2.40433058
3.35320095
97.59566942
3.35320095
6.41852182
0.79084226
93.58147818
0.79084226
0.00000000
100.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
50.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
Alger Mid Cap 40 ETF
S000069955
N
12500.00000000
6.50986428
1.64095280
93.49013572
1.64095280
7.89553579
2.02912528
92.10446421
2.02912528
0.00000000
160.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
160.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
Alger Weatherbie Enduring Growth ETF
S000079631
N
12500.00000000
7.77582460
1.23048758
92.22417540
1.23048758
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
133.33333333
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
Alger_ETF_Trust.txt
AUDITOR'S LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders of Alger 35 ETF, Alger Mid Cap 40 ETF and Alger Weatherbie
Enduring Growth ETF and the Board of Trustees of The Alger ETF Trust:
In planning and performing our audits of the financial statements of The Alger
ETF Trust (the "Trust"), including Alger 35 ETF, Alger Mid Cap 40 ETF and Alger
Weatherbie Enduring Growth ETF, as of and for the period or year ended December
31, 2023, in accordance with the standards of the Public Company Accounting
Oversight Board (United States) (PCAOB), we considered the Trust's internal
control over financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing procedures for the purpose of
expressing our opinion on the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose of expressing an opinion on
the effectiveness of the Trust's internal control over financial reporting.
Accordingly, we express no such opinion.
The management of the Trust is responsible for establishing and maintaining
effective internal control over financial reporting. In fulfilling this
responsibility, estimates and judgments by management are required to assess
the expected benefits and related costs of controls. A trust's internal control
over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally
accepted accounting principles. A trust's internal control over financial
reporting includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the trust; (2)
provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the trust
are being made only in accordance with authorizations of management and
directors of the trust; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use, or disposition
of a trust's assets that could have a material effect on the financial
statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions or that the degree of
compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the
design or operation of a control does not allow management or employees, in the
normal course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement of the
trust's annual or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Trust's internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be
material weaknesses under standards established by the PCAOB. However, we noted
no deficiencies in the Trust's internal control over financial reporting and
its operation, including controls for safeguarding securities, that we consider
to be a material weakness, as defined above, as of December 31, 2023.
This report is intended solely for the information and use of management and
the Board of Trustees of the Trust and the Securities and Exchange Commission
and is not intended to be and should not be used by anyone other than these
specified parties.
Deloitte & Touche LLP
New York, New York
February 26, 2024